314 related articles for article (PubMed ID: 15914111)
1. Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts.
Di Napoli P; Taccardi AA; Grilli A; De Lutiis MA; Barsotti A; Felaco M; De Caterina R
Cardiovasc Res; 2005 Jun; 66(3):462-71. PubMed ID: 15914111
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts.
Di Napoli P; Antonio Taccardi A; Grilli A; Spina R; Felaco M; Barsotti A; De Caterina R
Cardiovasc Res; 2001 Aug; 51(2):283-93. PubMed ID: 11470468
[TBL] [Abstract][Full Text] [Related]
3. [Simvastatin and ischemia-reperfusion damage: its effects on apoptotic myocyte death and on the endothelial expression of nitric-oxide synthetase in an experimental model of the isolated rat heart].
Di Napoli P; Maggi A; Spina R; Barsotti L; Taccardi AA; Stuppia L; Vianale G; Palka G; Barsotti A
Cardiologia; 1999 Jan; 44(1):69-74. PubMed ID: 10188333
[TBL] [Abstract][Full Text] [Related]
4. Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions.
Die J; Wang K; Fan L; Jiang Y; Shi Z
Brain Res; 2010 Jul; 1346():251-61. PubMed ID: 20513366
[TBL] [Abstract][Full Text] [Related]
5. Selective modulation of endogenous nitric oxide formation in ischemia/reperfusion injury in isolated rat hearts--effects on regional myocardial flow and enzyme release.
Han H; Kaiser R; Hu K; Laser M; Ertl G; Bauersachs J
Basic Res Cardiol; 2003 May; 98(3):165-74. PubMed ID: 12883834
[TBL] [Abstract][Full Text] [Related]
6. Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1/-2.
Kilic U; Bassetti CL; Kilic E; Xing H; Wang Z; Hermann DM
Neuroscience; 2005; 134(3):901-6. PubMed ID: 16009498
[TBL] [Abstract][Full Text] [Related]
7. Oral pre-treatment with rosuvastatin protects porcine myocardium from ischaemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level.
Bulhak AA; Gourine AV; Gonon AT; Sjöquist PO; Valen G; Pernow J
Acta Physiol Scand; 2005 Feb; 183(2):151-9. PubMed ID: 15676056
[TBL] [Abstract][Full Text] [Related]
8. The dual effects of nitric oxide synthase inhibitors on ischemia-reperfusion injury in rat hearts.
Kobara M; Tatsumi T; Takeda M; Mano A; Yamanaka S; Shiraishi J; Keira N; Matoba S; Asayama J; Nakagawa M
Basic Res Cardiol; 2003 Sep; 98(5):319-28. PubMed ID: 12955405
[TBL] [Abstract][Full Text] [Related]
9. [Effect of 17beta-estradiol on myocardial inducible NOS and endothelial NOS activities after ischemia-reperfusion in rat heart model].
Wang XD; Wang ZM; Jia DL; Yu P
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1789-91. PubMed ID: 17919391
[TBL] [Abstract][Full Text] [Related]
10. Late protective effect of pharmacological preconditioning with total flavones of rhododendra against myocardial ischemia-reperfusion injury.
Zhang JH; Chen ZW; Wu Z
Can J Physiol Pharmacol; 2008 Mar; 86(3):131-8. PubMed ID: 18418440
[TBL] [Abstract][Full Text] [Related]
11. MK-954 (losartan potassium) exerts endothelial protective effects against reperfusion injury: evidence of an e-NOS mRNA overexpression after global ischemia.
Barsotti A; Di Napoli P; Taccardi AA; Spina R; Stuppia L; Palka G; Barbacane RC; De Caterina R; Conti P
Atherosclerosis; 2001 Mar; 155(1):53-9. PubMed ID: 11223426
[TBL] [Abstract][Full Text] [Related]
12. Role of platelet activating factor in cardiac dysfunction, apoptosis and nitric oxide synthase mRNA expression in the ischemic-reperfused rabbit heart.
Loucks EB; Godin DV; Walley KR; McManus BM; Rahimian R; Granville DJ; Hong JM; Aktary FM; Qayumi AK
Can J Cardiol; 2003 Mar; 19(3):267-74. PubMed ID: 12677282
[TBL] [Abstract][Full Text] [Related]
13. Rosuvastatin prevents conduit artery endothelial dysfunction induced by ischemia and reperfusion by a cyclooxygenase-2-dependent mechanism.
Liuni A; Luca MC; Gori T; Parker JD
J Am Coll Cardiol; 2010 Mar; 55(10):1002-6. PubMed ID: 20202516
[TBL] [Abstract][Full Text] [Related]
14. Metabolic and functional protection by selective inhibition of nitric oxide synthase 2 during ischemia-reperfusion in isolated perfused hearts.
Ramasamy R; Hwang YC; Liu Y; Son NH; Ma N; Parkinson J; Sciacca R; Albala A; Edwards N; Szabolcs MJ; Cannon PJ
Circulation; 2004 Apr; 109(13):1668-73. PubMed ID: 15051645
[TBL] [Abstract][Full Text] [Related]
15. Propofol improves cardiac functional recovery after ischemia-reperfusion by upregulating nitric oxide synthase activity in the isolated rat hearts.
Sun HY; Xue FS; Xu YC; Li CW; Xiong J; Liao X; Zhang YM
Chin Med J (Engl); 2009 Dec; 122(24):3048-54. PubMed ID: 20137500
[TBL] [Abstract][Full Text] [Related]
16. Rosuvastatin given during reperfusion decreases infarct size and inhibits matrix metalloproteinase-2 activity in normocholesterolemic and hypercholesterolemic rabbits.
D'Annunzio V; Donato M; Erni L; Miksztowicz V; Buchholz B; Carrión CL; Schreier L; Wikinski R; Gelpi RJ; Berg G; Basso N
J Cardiovasc Pharmacol; 2009 Feb; 53(2):137-44. PubMed ID: 19188835
[TBL] [Abstract][Full Text] [Related]
17. Delayed 24 hours Nomega-nitro-L-arginine methyl ester injection induces pharmacological cardioprotection against reperfusion injury.
Davani S; Vergely C; Royer B; Bouhaddi M; Reyssie H; Rochette L; Kantelip JP
Cell Mol Biol (Noisy-le-grand); 2007 Jan; 52 Suppl():OL868-73. PubMed ID: 17543224
[TBL] [Abstract][Full Text] [Related]
18. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
[TBL] [Abstract][Full Text] [Related]
19. [Myocardial ischemic reperfusion injury affected by the isozymes of nitric oxide synthase and their gene expression: experimental study].
Cui S; Zhu H
Zhonghua Yi Xue Za Zhi; 1998 May; 78(5):327-30. PubMed ID: 10923431
[TBL] [Abstract][Full Text] [Related]
20. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
